Wednesday, Apr 01st
Last update08:00:43 AM GMT
Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Lilly's research showed some patients on Zyprexa gained as much as 80 pounds and that the incidence of high blood sugar at diabetes levels was 3.5 times higher than for placebos, according to documents filed in a lawsuit brought by the state of Alaska.
 The Supreme Court sided with a Christian counselor on Tuesday in her free speech challenge to... |
 A new COVID-19 variant, BA.3.2, has been detected in 25 states, according to a recent report... | ||
 The abortion rate is holding steady in the US despite total and partial bans in some... |
 A New Mexico jury determined Tuesday that Meta knowingly harmed children's mental health and concealed what... |
